Back to results

Study Assessing the Effectiveness of a Cardiac Web-based eLearning Platform (eEduHeart I)

Primary Purpose

Coronary Artery Disease

Status

Completed

Phase

Not Applicable

Locations

Belgium

Study Type

Interventional

Intervention

Intervention group

Control group

About this trial

This is an interventional prevention trial for Coronary Artery Disease focused on measuring E-Learning, coronary artery disease, telerehabilitation, e-health

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Patients suffering from coronary artery disease for which they are treated conservatively, with a percutaneous coronary intervention or with coronary artery bypass grafting

Exclusion Criteria:

Patients with dementia or cognitive impairment not being able to sufficiently understand the E-Learning packages content
(Foreign) patients unable to speak Dutch, thereby not being able to understand the content of the E-Learning packages
Patients with advanced visual and/or auditory impairments, hindering them to adequately understand the E-earning packages
Patients participating in another trial during the Pilot study period
Patients refusing to provide signed consent

Sites / Locations

ZOL
Jessa Ziekenhuis

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Intervention group

Control group

Arm Description

The intervention group patients have access to the eLearning platform in addition to conventional cardiac care.

The control group patients receive conventional cardiac care alone.

Outcomes

Primary Outcome Measures

Health-related quality of life

Health-related quality of life, assessed by HeartQol

Secondary Outcome Measures

Adherence to the E-learning packages

Adherence to the E-learning packages as assessed by the number of logs and the cumulative log time on the E-learning platform per patient.

Effectiveness of E-learning packages

Effectiveness of intervention in improving patients' knowledge of cardiac diseases as assessed by questionnaire scores.

User experience of eLearning platform

Asses user experience of eLearning platform by User Experience Questionnaire (UEQ)

Full Information

NCT ID

NCT02475967

First Posted

June 10, 2015

Last Updated

February 26, 2018

Sponsor

Hasselt University

Collaborators

Jessa Hospital

1. Study Identification

Unique Protocol Identification Number

NCT02475967

Brief Title

Study Assessing the Effectiveness of a Cardiac Web-based eLearning Platform

Acronym

eEduHeart I

Official Title

eEduHeart I: a Multi-center Randomized, Controlled Trial Investigating the Effectiveness of a Cardiac Web-based eLearning Platform

Study Type

Interventional

2. Study Status

Record Verification Date

February 2018

Overall Recruitment Status

Completed

Study Start Date

January 2016 (undefined)

Primary Completion Date

February 2018 (Actual)

Study Completion Date

February 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title

Principal Investigator

Name of the Sponsor

Hasselt University

Collaborators

Jessa Hospital

4. Oversight

Data Monitoring Committee

5. Study Description

Brief Summary

In the trial cardiac patients will be provided with unrestricted access to the web-based eLearing platform for a one-month period.

Detailed Description

Patients participating in the trial will be provided with a cardiac web-based eLearning platform for one month during study period. The medical content of the packages will be gathered from a multidisciplinary input of both medics (e.g. cardiologists) and paramedics (e.g. psychologists). E-Learning packages type I: videos with information from caregivers. In these videos, medics and paramedics are interviewed to highlight the etiology, pathophysiology and treatment of coronary artery disease; the associated comorbidities and the ways to prevent recurrence. E-Learning packages type II: videos in which patients are interviewed. Patients can help each other to adhere to their treatment plan, by sharing stories from their own experience about their illness and the rehabilitation afterwards. Short clips of maximum 2 minutes will be provided to study participants.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study

Coronary Artery Disease

Keywords

E-Learning, coronary artery disease, telerehabilitation, e-health

7. Study Design

Primary Purpose

Prevention

Study Phase

Not Applicable

Interventional Study Model

Parallel Assignment

Masking

Outcomes Assessor

Allocation

Randomized

Enrollment

1000 (Actual)

8. Arms, Groups, and Interventions

Arm Title

Intervention group

Arm Type

Experimental

Arm Description

The intervention group patients have access to the eLearning platform in addition to conventional cardiac care.

Arm Title

Control group

Arm Type

Active Comparator

Arm Description

The control group patients receive conventional cardiac care alone.

Intervention Type

Other

Intervention Name(s)

Intervention group

Intervention Description

The intervention group patients have access to the eLearning platform in addition to conventional cardiac care.The content of platform will be gathered from a multidisciplinary input of both medics (e.g. cardiologists) and paramedics (e.g. psychologists). Patients will also contribute to platform content.

Intervention Type

Other

Intervention Name(s)

Control group

Intervention Description

The control group patients receive conventional cardiac care alone.

Primary Outcome Measure Information:

Title

Health-related quality of life

Description

Health-related quality of life, assessed by HeartQol

Time Frame

3 months

Secondary Outcome Measure Information:

Title

Adherence to the E-learning packages

Description

Adherence to the E-learning packages as assessed by the number of logs and the cumulative log time on the E-learning platform per patient.

Time Frame

3 months

Title

Effectiveness of E-learning packages

Description

Effectiveness of intervention in improving patients' knowledge of cardiac diseases as assessed by questionnaire scores.

Time Frame

3 months

Title

User experience of eLearning platform

Description

Asses user experience of eLearning platform by User Experience Questionnaire (UEQ)

Time Frame

3 months

10. Eligibility

Sex

All

Minimum Age & Unit of Time

18 Years

Accepts Healthy Volunteers

Eligibility Criteria

Inclusion Criteria: Patients suffering from coronary artery disease for which they are treated conservatively, with a percutaneous coronary intervention or with coronary artery bypass grafting Exclusion Criteria: Patients with dementia or cognitive impairment not being able to sufficiently understand the E-Learning packages content (Foreign) patients unable to speak Dutch, thereby not being able to understand the content of the E-Learning packages Patients with advanced visual and/or auditory impairments, hindering them to adequately understand the E-earning packages Patients participating in another trial during the Pilot study period Patients refusing to provide signed consent

Overall Study Officials:

First Name & Middle Initial & Last Name & Degree

Ines Frederix, drs.

Organizational Affiliation

Hasselt University

Official's Role

Study Chair

Facility Information:

Facility Name

ZOL

City

Genk

ZIP/Postal Code

3600

Country

Belgium

Facility Name

Jessa Ziekenhuis

City

Hasselt

ZIP/Postal Code

3500

Country

Belgium

12. IPD Sharing Statement

Plan to Share IPD

Undecided

Learn more about this trial

Study Assessing the Effectiveness of a Cardiac Web-based eLearning Platform

We'll reach out to this number within 24 hrs